Basic Information
| RNALocate ID: | RLID-D:11000117 |
| RNA Symbol: | hsa-miR-361-5p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-361-5p |
| RNA ID: | miRBase:MIMAT0000703 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| Tissue/Cell Line: | Blood|Kidney tissue |
| Database: | EVmiRNA |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01002009 | Cytoplasm | Nasopharyngeal carcinoma cells | 20498841 |
| RLID:01002010 | Cytoplasm | Neural progenitor cells | 21363885 |
| RLID:01002011 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01002012 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:01002013 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01002014 | Nucleus | Nasopharyngeal carcinoma cells | 20498841 |
| RLID:11002414 | Exosome | Serum | 18589210 |
| RLID:11002415 | Exosome | Breast cancer cell line (MCF-7) | 20976003 |
| RLID:11002416 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
| RLID:11002417 | Exosome | Renal cancer cells | 21670082 |
| RLID:11002418 | Exosome | Brain tissue | 23382797 |
| RLID:11002419 | Exosome | Plasma | 23663360 |
| RLID:11002420 | Exosome | Human mast cell line (HMC-1) | 24009880 |
| RLID:11002421 | Exosome | Serum | 25349172 |
| RLID:11002422 | Extracellular vesicle | HEK-293T cells | 22849433 |
| RLID:11002423 | Microvesicle | Seminal plasma | 23539611 |
| RLID-D:11000406 | Microvesicle | Blood|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-361-5p | Oral squamous cell carcinoma | MNDR-E-MI-43463 |
| MNDR | hsa-miR-361-5p | Medulloblastoma | MNDR-E-MI-43464 |
| MNDR | hsa-miR-361-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-43465 |
| MNDR | hsa-miR-361-5p | Lymphoma | MNDR-E-MI-43466 |
| MNDR | hsa-miR-361-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-43467 |
| MNDR | hsa-miR-361-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-43468 |
| MNDR | hsa-miR-361-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-43469 |
| MNDR | hsa-miR-361-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-43470 |
| MNDR | hsa-miR-361-5p | Her2-receptor positive breast cancer | MNDR-E-MI-43471 |
| MNDR | hsa-miR-361-5p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-43472 |
| MNDR | hsa-miR-361-5p | B cell acute lymphoblastic leukemia | MNDR-E-MI-43473 |
| MNDR | hsa-miR-361-5p | Dermatomyositis | MNDR-E-MI-43474 |
| MNDR | hsa-miR-361-5p | Prostate cancer | MNDR-E-MI-43475 |
| MNDR | hsa-miR-361-5p | Gastric cancer | MNDR-E-MI-43476 |
| MNDR | hsa-miR-361-5p | Alzheimer disease | MNDR-E-MI-43477 |
| MNDR | hsa-miR-361-5p | Intracranial aneurysm | MNDR-E-MI-43478 |
| MNDR | hsa-miR-361-5p | Dysautonomia familial | MNDR-E-MI-43479 |
| MNDR | hsa-miR-361-5p | Muscular dystrophy duchenne | MNDR-E-MI-43480 |
| MNDR | hsa-miR-361-5p | Primary biliary cirrhosis | MNDR-E-MI-43481 |
| MNDR | hsa-miR-361-5p | Graves disease | MNDR-E-MI-43482 |
| MNDR | hsa-miR-361-5p | Leukemia | MNDR-E-MI-43483 |
| MNDR | hsa-miR-361-5p | Cardiovascular disease | MNDR-E-MI-43484 |
| MNDR | hsa-miR-361-5p | Carotid stenosis | MNDR-E-MI-43485 |
| MNDR | hsa-miR-361-5p | Moyamoya disease | MNDR-E-MI-43486 |
| MNDR | hsa-miR-361-5p | Lung cancer | MNDR-E-MI-43487 |
| MNDR | hsa-miR-361-5p | Parkinson disease | MNDR-E-MI-43488 |
| MNDR | hsa-miR-361-5p | Breast cancer | MNDR-E-MI-43489 |
| MNDR | hsa-miR-361-5p | Pituitary neoplasms | MNDR-E-MI-43490 |
| MNDR | hsa-miR-361-5p | Pancreatic cancer | MNDR-E-MI-43491 |
| MNDR | hsa-miR-361-5p | Melanoma | MNDR-E-MI-43492 |
| MNDR | hsa-miR-361-5p | Nephroblastoma | MNDR-E-MI-43493 |
| MNDR | hsa-miR-361-5p | Colon cancer | MNDR-E-MI-43494 |
| MNDR | hsa-miR-361-5p | Relapsing-remitting multiple sclerosis | MNDR-E-MI-43495 |
| MNDR | hsa-miR-361-5p | Ovarian cancer | MNDR-E-MI-43496 |
| MNDR | hsa-miR-361-5p | Prostate adenocarcinoma | MNDR-E-MI-43497 |
| MNDR | hsa-miR-361-5p | Carcinoma ductal breast | MNDR-E-MI-43498 |
| MNDR | hsa-miR-361-5p | Glioblastoma | MNDR-E-MI-43499 |
| MNDR | hsa-miR-361-5p | Glioma | MNDR-E-MI-43500 |
| MNDR | hsa-miR-361-5p | Central nervous system lymphoma | MNDR-E-MI-43501 |
| MNDR | hsa-miR-361-5p | Chordoma | MNDR-E-MI-43502 |
| MNDR | hsa-miR-361-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-43503 |
| MNDR | hsa-miR-361-5p | Epilepsy temporal lobe | MNDR-E-MI-43504 |
| MNDR | hsa-miR-361-5p | Osteosarcoma | MNDR-E-MI-43505 |
| MNDR | hsa-miR-361-5p | Inclusion body myositis | MNDR-E-MI-43506 |
| MNDR | hsa-miR-361-5p | Pancreatic ductal adenocarcinoma | MNDR-E-MI-43507 |
| MNDR | hsa-miR-361-5p | Gastric adenocarcinoma | MNDR-E-MI-43508 |
| MNDR | hsa-miR-361-5p | Cervical squamous cell carcinoma | MNDR-E-MI-43509 |
| MNDR | hsa-miR-361-5p | Pituitary adenoma | MNDR-E-MI-43510 |
| MNDR | hsa-miR-361-5p | Lung squamous cell carcinoma | MNDR-E-MI-43511 |
| MNDR | hsa-miR-361-5p | Non-small cell lung cancer | MNDR-E-MI-43512 |
| MNDR | hsa-miR-361-5p | Lung adenocarcinoma | MNDR-E-MI-43513 |
| MNDR | hsa-miR-361-5p | Adrenocortical cancer | MNDR-E-MI-43514 |
| MNDR | hsa-miR-361-5p | Thyroid carcinoma | MNDR-E-MI-43515 |
| MNDR | hsa-miR-361-5p | Papillary thyroid carcinoma | MNDR-E-MI-43516 |
| MNDR | hsa-miR-361-5p | Bladder urothelial carcinoma | MNDR-E-MI-43517 |
| MNDR | hsa-miR-361-5p | Pancreatic adenocarcinoma | MNDR-E-MI-43518 |
| MNDR | hsa-miR-361-5p | Carcinoma renal cell | MNDR-E-MI-43519 |
| MNDR | hsa-miR-361-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-43520 |
| MNDR | hsa-miR-361-5p | Clear cell renal cell carcinoma | MNDR-E-MI-43521 |
| MNDR | hsa-miR-361-5p | Cholangiocarcinoma | MNDR-E-MI-43522 |
| MNDR | hsa-miR-361-5p | Pancreatitis | MNDR-E-MI-43523 |
| MNDR | hsa-miR-361-5p | Esophageal cancer | MNDR-E-MI-43524 |
| MNDR | hsa-miR-361-5p | Lung small cell carcinoma | MNDR-E-MI-43525 |
| MNDR | hsa-miR-361-5p | Encephalopathy bovine spongiform | MNDR-E-MI-43526 |
| MNDR | hsa-miR-361-5p | Synovial sarcoma | MNDR-E-MI-43527 |
| MNDR | hsa-miR-361-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-43528 |
| MNDR | hsa-miR-361-5p | Adenoma | MNDR-E-MI-43529 |
| MNDR | hsa-miR-361-5p | Breast invasive carcinoma | MNDR-E-MI-43530 |
| MNDR | hsa-miR-361-5p | Hepatocellular carcinoma | MNDR-E-MI-43531 |
| MNDR | hsa-miR-361-5p | B-cell lymphoma | MNDR-E-MI-43532 |
| MNDR | hsa-miR-361-5p | Rheumatoid arthritis | MNDR-E-MI-43533 |
| MNDR | hsa-miR-361-5p | Hodgkin lymphoma | MNDR-E-MI-43534 |
| MNDR | hsa-miR-361-5p | Burkitt lymphoma | MNDR-E-MI-43535 |
| MNDR | hsa-miR-361-5p | Neuromyelitis optica | MNDR-E-MI-43536 |
| MNDR | hsa-miR-361-5p | Colorectal cancer | MNDR-E-MI-43537 |
| MNDR | hsa-miR-361-5p | Nasopharynx carcinoma | MNDR-E-MI-43538 |
| MNDR | hsa-miR-361-5p | Nasopharyngeal cancer | MNDR-E-MI-43539 |
| MNDR | hsa-miR-361-5p | Stroke lacunar | MNDR-E-MI-43540 |
| MNDR | hsa-miR-361-5p | Breast cancer her3+ negative | MNDR-E-MI-43541 |
| MNDR | hsa-miR-361-5p | Cutaneous squamous cell carcinoma | MNDR-E-MI-43542 |
| MNDR | hsa-miR-361-5p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-43543 |
| MNDR | hsa-miR-361-5p | Tubulovillous adenoma | MNDR-E-MI-43544 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ABCB1 | Homo sapiens | RR00022785 |
TOP